Jane Street’s ClearPoint Neuro CLPT Stock Holding History

Jane Street’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$379K	Sell	41,600 -14,000	-25%	-$177K	﹤0.01%	8688
2025 Q4	$761K	Sell	55,600 -59,800	-52%	-$1.11M	﹤0.01%	6746
2025 Q3	$2.51M	Buy	115,400 +98,000	+563%	+$1.15M	﹤0.01%	4521
2025 Q2	$208K	Buy	+17,400	New	+$219K	﹤0.01%	8481
2022 Q1	–	Sell	-13,700	Closed	-$154K	–	10349
2021 Q4	$154K	Sell	13,700 -8,800	-39%	-$132K	﹤0.01%	8986
2021 Q3	$399K	Buy	+22,500	New	+$422K	﹤0.01%	7685

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Jane Street's CLPT Position: Q1 2026 in Review

Jane Street sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 35,124 shares — an estimated $443K sold.

Jane Street first reported a position in CLPT in Q3 2021 and held it in 12 quarters. The position peaked at $3.42M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Jane Street reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
Jane Street sold 35,124 ClearPoint Neuro shares in Q1 2026, an estimated $443K.
Jane Street first reported a position in ClearPoint Neuro in Q3 2021 and held it in 12 quarters.
Jane Street's ClearPoint Neuro position peaked at $3.42M in Q4 2024.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.